Identification of GALNT14 as a novel neuroblastoma predisposition gene

scientific article published on 3 July 2015

Identification of GALNT14 as a novel neuroblastoma predisposition gene is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.4501
P932PMC publication ID4694905
P698PubMed publication ID26309160
P5875ResearchGate publication ID281342952

P50authorSilvano FerriniQ39791275
Luca LongoQ54265560
Marco ChiericiQ55298377
Alberto GaraventaQ57072396
Massimo ConteQ57307345
Michela CroceQ84277400
P2093author name stringGian Paolo Tonini
Cesare Furlanello
Marilena De Mariano
Roberta Gallesio
P2860cites workOncogenic mutations of ALK kinase in neuroblastomaQ39928776
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastomaQ39928780
TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window.Q40165924
ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.Q40250682
Germline PHOX2B mutation in hereditary neuroblastomaQ42586619
Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.Q43225298
UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.Q53352914
NeuroblastomaQ54265665
Recent advances in neuroblastomaQ56637924
Genetic Predisposition to Familial Neuroblastoma: Identification of Two Novel Genomic Regions at 2p and 12pQ58328226
PHOX2B mutations and genetic predisposition to neuroblastomaQ58328232
Oligogenic inheritance in neuroblastomaQ60035816
Targeted capture and massively parallel sequencing of 12 human exomesQ24615381
Common variations in BARD1 influence susceptibility to high-risk neuroblastomaQ24645352
N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancersQ24648283
Fast and accurate short read alignment with Burrows-Wheeler transformQ24653853
Identification of ALK as a major familial neuroblastoma predisposition geneQ24655923
Chromosome 6p22 locus associated with clinically aggressive neuroblastomaQ24656264
Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene familyQ26864268
Activating mutations in ALK provide a therapeutic target in neuroblastomaQ27851452
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.Q27852211
A method and server for predicting damaging missense mutationsQ27860835
The Sequence Alignment/Map format and SAMtoolsQ27860966
The genomic landscapes of human breast and colorectal cancersQ27861078
Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14Q28200937
The epidemiology of neuroblastoma: a reviewQ28307370
The lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 is involved in O-glycosylation of a polypeptide with multiple acceptor sitesQ28571370
An exploratory study of ambient air toxics exposure in pregnancy and the risk of neuroblastoma in offspringQ28657377
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastomaQ28943271
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmQ29547194
N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistryQ33548177
Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.Q33855434
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastomaQ33909753
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.Q34006269
VarScan: variant detection in massively parallel sequencing of individual and pooled samplesQ34018143
Integrative genomics identifies LMO1 as a neuroblastoma oncogeneQ34152903
Neuroblastoma: biological insights into a clinical enigmaQ34180699
A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinomaQ34365193
Death to the bad guys: targeting cancer via Apo2L/TRAIL.Q36042489
The potential of death receptor 4- and 5-directed therapies in the treatment of lung cancerQ36903123
The genetic landscape of high-risk neuroblastomaQ36929803
Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancersQ37293142
New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK.Q38130615
GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.Q38981475
GALNT9 gene expression is a prognostic marker in neuroblastoma patientsQ39247881
Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesisQ39730101
P433issue28
P407language of work or nameEnglishQ1860
P921main subjectneuroblastomaQ938205
P304page(s)26335-26346
P577publication date2015-09-01
P1433published inOncotargetQ1573155
P1476titleIdentification of GALNT14 as a novel neuroblastoma predisposition gene
P478volume6

Reverse relations

cites work (P2860)
Q30252766A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.
Q47839039Cell death-based treatment of neuroblastoma
Q52793910Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
Q94595614Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer
Q33710048GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma
Q42232294GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma.
Q37519157GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment
Q89879441GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
Q39273903Genetic susceptibility to neuroblastoma
Q52339753Genetic susceptibility to neuroblastoma: current knowledge and future directions.
Q98177546Genomic Analysis Identifies New Loci Associated With Motor Complications in Parkinson's Disease
Q52667529Investigating piwi-interacting RNA regulome in human neuroblastoma.
Q38702196Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.
Q57493791Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and Genotype
Q64264952Rare copy number variants contribute pathogenic alleles in patients with intestinal malrotation
Q39412574Retinoblastoma and Neuroblastoma Predisposition and Surveillance
Q39208675The MYCN Protein in Health and Disease

Search more.